Combined Modality TherapyFluorouracilRadiotherapyRadiotherapy DosageRadiation InjuriesRadiotherapy, ConformalRadiotherapy, AdjuvantRadiation DosageAntineoplastic AgentsRadiation, IonizingDose-Response Relationship, RadiationRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRadiation ToleranceRadiotherapy, High-EnergyRadiation OncologyDose FractionationNeoplasmsCell Line, TumorRadiationRadiotherapy, Computer-AssistedRadiation ProtectionRadiotherapy, Image-GuidedDrug Screening Assays, AntitumorRadiation MonitoringCisplatinDoxorubicinTreatment OutcomeRadiation-Sensitizing AgentsRadiation PneumonitisBrachytherapyApoptosisHead and Neck NeoplasmsNeoplasms, Radiation-InducedAntineoplastic Combined Chemotherapy ProtocolsRadiometryRadiosurgeryBrain NeoplasmsCell SurvivalDrug Resistance, NeoplasmNeoplasm Recurrence, LocalAntineoplastic Agents, PhytogenicNeoplasm StagingCarcinoma, Squamous CellChemoradiotherapyBreast NeoplasmsGamma RaysTime FactorsRadiation Injuries, ExperimentalLung NeoplasmsAntibiotics, AntineoplasticRetrospective StudiesDisease-Free SurvivalTumor Cells, CulturedDrug Delivery SystemsMice, NudeEtoposideNasopharyngeal NeoplasmsXenograft Model Antitumor AssaysSurvival RateSurvival AnalysisParticle AcceleratorsRadiation-Protective AgentsDNA DamageOrgans at RiskFollow-Up StudiesCosmic RadiationRadiodermatitisCranial IrradiationPrognosisCell ProliferationChemotherapy, AdjuvantDrug CarriersCobalt RadioisotopesVincristinePaclitaxelRectal NeoplasmsProstatic NeoplasmsAdenocarcinomaDose-Response Relationship, DrugDacarbazineAntineoplastic Agents, AlkylatingTomography, X-Ray ComputedCamptothecinBleomycinBackground RadiationEllipticinesGlioblastomaUltraviolet RaysTumor BurdenVinblastinePelvic NeoplasmsCell CycleAntimetabolites, AntineoplasticMastectomy, SegmentalCarcinoma, Non-Small-Cell LungRadiobiologyGliomaHodgkin DiseaseLaryngeal Neoplasms